Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V De Ledinghen

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|October 2, 2007
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotypeL Castéra, M A Loko, B Le Bail, et al.
Journal of Hepatology|March 6, 1999
Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturationJ F Blanc, V De Ledinghen, P Trimoulet, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 10, 2013
Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantationB Taton, K Moreau, S Lepreux, et al.
Digestive Diseases and Sciences|March 1, 2000
Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alphaP Trimoulet, P H Bernard, V de Ledinghen, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2007
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentationT Poynard, P Halfon, L Castera, et al.
Journal of Viral Hepatitis|May 6, 2009
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infectionL Martin-Carbonero, V de Ledinghen, A Moreno, et al.
Journal of Hepatology|June 14, 2000
Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liverJ F Blanc, V De Ledinghen, P H Bernard, et al.
Gastroenterologie Clinique Et Biologique|June 29, 2010
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measureT Poynard, M Munteanu, Y Ngo, et al.
Journal of Viral Hepatitis|March 13, 2012
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis CM Sasso, I Tengher-Barna, M Ziol, et al.
Journal of Viral Hepatitis|June 20, 2007
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infectionD Roulot, V Bourcier, V Grando, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|October 2, 2007
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotypeL Castéra, M A Loko, B Le Bail, et al.
Journal of Hepatology|March 6, 1999
Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturationJ F Blanc, V De Ledinghen, P Trimoulet, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 10, 2013
Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantationB Taton, K Moreau, S Lepreux, et al.
Digestive Diseases and Sciences|March 1, 2000
Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alphaP Trimoulet, P H Bernard, V de Ledinghen, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2007
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentationT Poynard, P Halfon, L Castera, et al.
Journal of Viral Hepatitis|May 6, 2009
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infectionL Martin-Carbonero, V de Ledinghen, A Moreno, et al.
Journal of Hepatology|June 14, 2000
Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liverJ F Blanc, V De Ledinghen, P H Bernard, et al.
Gastroenterologie Clinique Et Biologique|June 29, 2010
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measureT Poynard, M Munteanu, Y Ngo, et al.
Journal of Viral Hepatitis|March 13, 2012
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis CM Sasso, I Tengher-Barna, M Ziol, et al.
Journal of Viral Hepatitis|June 20, 2007
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infectionD Roulot, V Bourcier, V Grando, et al.
Pageof 3